NIAID Banner Logo Image

Mycobacterium Citations List: March, 2018

Literature Citations

1. Dimers of Coumarin-1,2,3-triazole Hybrids Bearing Alkyl Spacer: Design, Microwave-assisted Synthesis, Molecular Docking and Evaluation as Antimycobacterial and Antimicrobial Agents. Ashok, D., S. Gundu, V.K. Aamate, M.G. Devulapally, R. Bathini, and V. Manga. Journal of Molecular Structure, 2018. 1157: p. 312-321. ISI[000425197400035].
[WOS]. TB_03_2018.


2. Mycelial Growth and Antimicrobial Activity of Species of Genus Lentinus (Agaricomycetes) from Brazil.Castillo, T.A., J.R.G. Pereira, J.M.A. Alves, and M.F.S. Teixeira. International Journal of Medicinal Mushrooms, 2017. 19(12): p. 1135-1143. PMID[29431074].
[PubMed]. TB_03_2018.


3. Anti-proliferative and Anti-inflammatory Lanostane Triterpenoids from the Polish Edible Mushroom Macrolepiota procera. Chen, H.P., Z.Z. Zhao, Z.H. Li, Y. Huang, S.B. Zhang, Y. Tang, J.N. Yao, L. Chen, M. Isaka, T. Feng, and J.K. Liu. Journal of Agricultural and Food Chemistry, 2018. 66(12): p. 3146-3154. PMID[29510036].
[PubMed]. TB_03_2018.


4. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice. Choi, S.R., B.E. Britigan, B. Switzer, T. Hoke, D. Moran, and P. Narayanasamy. Molecular Pharmaceutics, 2018. 15(3): p. 1215-1225. PMID[29421865].
[PubMed]. TB_03_2018.


5. In Vitro Activity of Tedizolid against the Mycobacterium abscessus Complex. Compain, F., D. Soroka, B. Heym, J.L. Gaillard, J.L. Herrmann, D. Dorchene, M. Arthur, and V. Dubee. Diagnostic Microbiology and Infectious Disease, 2018. 90(3): p. 186-189. PMID[29217419].
[PubMed]. TB_03_2018.


6. Synthesis, Biological Evaluation, and Molecular Docking Study of Pyridine Clubbed 1,3,4-Oxadiazoles as Potential Antituberculars. Desai, N.C., A. Trivedi, H. Somani, K.A. Jadeja, D. Vaja, L. Nawale, V.M. Khedkar, and D. Sarkar. Synthetic Communications, 2018. 48(5): p. 524-540. ISI[000426114000005].
[WOS]. TB_03_2018.


7. Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. Harbut, M.B., B. Yang, R. Liu, T. Yano, C. Vilcheze, B. Cheng, J. Lockner, H. Guo, C. Yu, S.G. Franzblau, H.M. Petrassi, W.R. Jacobs, Jr., H. Rubin, A.K. Chatterjee, and F. Wang. Angewandte Chemie, 2018. 57(13): p. 3478-3482. PMID[29388301].
[PubMed]. TB_03_2018.


8. Streptomyces puniceus Strain AS13., Production, Characterization and Evaluation of Bioactive Metabolites: A New Face of Dinactin as an Antitumor Antibiotic.Hussain, A., M.A. Rather, M.S. Dar, N.A. Dangroo, M.A. Aga, A. Qayum, A.M. Shah, Z. Ahmad, M.J. Dar, and Q.P. Hassan. Microbiological Research, 2018. 207: p. 196-202. PMID[29458855].
[PubMed]. TB_03_2018.


9. Computer-aided Drug Design of Capuramycin Analogues as Anti-tuberculosis Antibiotics by 3D-QSAR and Molecular Docking.Jin, Y., S. Fan, G. Lv, H. Meng, Z. Sun, W. Jiang, S.G. Van Lanen, and Z. Yang. Open Chemistry, 2017. 15(1): p. 299-307. ISI[000424997500001].
[WOS]. TB_03_2018.


10. Porous CuO Catalysed Green Synthesis of Some Novel 3-Alkylated indoles as Potent Antitubercular Agents.Khan, G.A., J.A. War, G.A. Naikoo, U.J. Pandit, and R. Das. Journal of Saudi Chemical Society, 2018. 22(1): p. 6-15. ISI[000425272600002].
[WOS]. TB_03_2018.


11. Anti-tubercular and Probiotic Properties of Coagulase-negative Staphylococci Isolated from Koozh, a Traditional Fermented Food of South India. Khusro, A., C. Aarti, A. Dusthackeer, and P. Agastian. Microbial Pathogenesis, 2018. 114: p. 239-250. PMID[2919617].
[PubMed]. TB_03_2018.


12. A Structure-based Strategy toward the Development of Novel Candidates for Antimycobacterial Activity: Synthesis, Biological Evaluation, and Docking Study. Li, L., Y. Jin, B. Wang, Z. Yang, M. Liu, H. Guo, J. Zhang, and Y. Lu. Chemical Biology & Drug Design, 2018. 91(3): p. 769-780. PMID[29130630].
[PubMed]. TB_03_2018.


13. Design, Synthesis, and Antifungal Activities of 3-Acyl thiotetronic acid Derivatives: New Fatty acid synthase Inhibitors. Lv, P., Y. Chen, Z. Zhao, T. Shi, X. Wu, J. Xue, Q.X. Li, and R. Hua. Journal of Agricultural and Food Chemistry, 2018. 66(4): p. 1023-1032. PMID[29290106].
[PubMed]. TB_03_2018.


14. Synthesis, Structural Studies and Antituberculosis Evaluation of New Hydrazone Derivatives of Quinoline and Their Zn(II) Complexes. Mandewale, M.C., B. Thorat, Y. Nivid, R. Jadhav, A. Nagarsekar, and R. Yamgar. Journal of Saudi Chemical Society, 2018. 22(2): p. 218-228. ISI[000425273800010].
[WOS]. TB_03_2018.


15. Naturally Occurring Diels-Alder-type Adducts from Morus nigra as Potent Inhibitors of Mycobacterium tuberculosis Protein Tyrosine phosphatase B. Mascarello, A., A.C. Orbem Menegatti, A. Calcaterra, P.G. Alves Martins, L.D. Chiaradia-Delatorre, I. D'Acquarica, F. Ferrari, V. Pau, A. Sanna, A. De Logu, M. Botta, B. Botta, H. Terenzi, and M. Mori. European Journal of Medicinal Chemistry, 2018. 144: p. 277-288. PMID[29275228].
[PubMed]. TB_03_2018.


16. Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors. Nastasa, C., D.C. Vodnar, I. Ionut, A. Stana, D. Benedec, R. Tamaian, O. Oniga, and B. Tiperciuc. International Journal of Molecular Sciences, 2018. 19(1): p. E222. PMID[29324679]. PMCID[PMC5796171].
[PubMed]. TB_03_2018.


17. Broad Activity of Diphenyleneiodonium Analogues against Mycobacterium tuberculosis, Malaria Parasites and Bacterial Pathogens. Nguyen, N., D.W. Wilson, G. Nagalingam, J.A. Triccas, E.K. Schneider, J. Li, T. Velkov, and J. Baell. European Journal of Medicinal Chemistry, 2018. 148: p. 507-518. PMID[29269132].
[PubMed]. TB_03_2018.


18. Synthesis, Antimicrobial Activity and Acid Dissociation Constants of Methyl 5,5-Diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate Derivatives. Nural, Y., M. Gemili, M. Ulger, H. Sari, L.M. De Coen, and E. Sahin. Bioorganic & Medicinal Chemistry Letters, 2018. 28(5): p. 942-946. PMID[29433925].
[PubMed]. TB_03_2018.


19. Synthesis, Antibacterial Activity and Molecular Docking of Substituted Naphthyridines as Potential DNA Gyrase Inhibitors. Omar, F.A., M. Abelrasoul, M.M. Sheha, H.Y. Hassan, and Y.M. Ibrahiem. ChemistrySelect, 2018. 3(9): p. 2604-2612. ISI[000426765100027].
[WOS]. TB_03_2018.


20. Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages. Paolino, M., M. Brindisi, A. Vallone, S. Butini, G. Campiani, C. Nannicini, G. Giuliani, M. Anzini, S. Lamponi, G. Giorgi, D. Sbardella, D.M. Ferraris, S. Marini, M. Coletta, I. Palucci, M. Minerva, G. Delogu, I. Pepponi, D. Goletti, A. Cappelli, S. Gemma, and S. Brogi. ChemMedChem, 2018. 13(5): p. 422-430. PMID[29334428].
[PubMed]. TB_03_2018.


21. Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-resistant Enterococci (VRE) in Vitro and in Vivo. Parmar, A., R. Lakshminarayanan, A. Iyer, V. Mayandi, E.T. Leng Goh, D.G. Lloyd, M.L.S. Chalasani, N.K. Verma, S.H. Prior, R.W. Beuerman, A. Madder, E.J. Taylor, and I. Singh. Journal of Medicinal Chemistry, 2018. 61(5): p. 2009-2017. PMID[29363971].
[PubMed]. TB_03_2018.


22. Phocoenamicins B and C, New Antibacterial Spirotetronates Isolated from a Marine Micromonospora sp. Perez-Bonilla, M., D. Oves-Costales, M. de la Cruz, M. Kokkini, J. Martin, F. Vicente, O. Genilloud, and F. Reyes. Marine Drugs, 2018. 16(3): p. E95. PMID[29547589]. PMCID[PMC5867639].
[PubMed]. TB_03_2018.


23. Synthetic Piperine amide Analogs with Antimycobacterial Activity. Philipova, I., V. Valcheva, R. Mihaylova, M. Mateeva, I. Doytchinova, and G. Stavrakov. Chemical Biology & Drug Design, 2018. 91(3): p. 763-768. PMID[29130602].
[PubMed]. TB_03_2018.


24. In Vivo Potent BM635 Analogue with Improved Drug-like Properties. Poce, G., M. Cocozza, S. Alfonso, S. Consalvi, G. Venditti, R. Fernandez-Menendez, R.H. Bates, D. Barros Aguirre, L. Ballell, A. De Logu, G. Vistoli, and M. Biava. European Journal of Medicinal Chemistry, 2018. 145: p. 539-550. PMID[29335214].
[PubMed]. TB_03_2018.


25. Chlorflavonin Targets Acetohydroxyacid synthase Catalytic Subunit IlvB1 for Synergistic Killing of Mycobacterium tuberculosis. Rehberg, N., H.S. Akone, T.R. Ioerger, G. Erlenkamp, G. Daletos, H. Gohlke, P. Proksch, and R. Kalscheuer. ACS Infectious Diseases, 2018. 4(2): p. 123-134. PMID[29108416].
[PubMed]. TB_03_2018.


26. Compounds with Potential Activity against Mycobacterium tuberculosis. Sao Emani, C., M.J. Williams, I.J. Wiid, B. Baker, and C. Carolis. Antimicrobial Agents and Chemotherapy, 2018. 62(4): p. e02236-02217. PMID[29437626].
[PubMed]. TB_03_2018.


27. The Frequently Occurring Components of Essential Oils beta Elemene and R-Limonene Alter Expression of dprE1 and clgR Genes of Mycobacterium tuberculosis H37Ra. Sawicki, R., E. Sieniawska, M. Swatko-Ossor, J. Golus, and G. Ginalska. Food and Chemical Toxicology, 2018. 112: p. 145-149. PMID[29288759].
[PubMed]. TB_03_2018.


28. Synthesis and Antimicrobial and Antituberculosis Activity of the First Conjugates of the Diterpenoid Isosteviol and D-Arabinofuranose. Sharipova, R.R., O.V. Andreeva, B.F. Garifullin, I.Y. Strobykina, A.S. Strobykina, A.D. Voloshina, M.A. Kravchenko, and V.E. Kataev. Chemistry of Natural Compounds, 2018. 54(1): p. 92-97. ISI[000425747600023].
[WOS]. TB_03_2018.


29. Nigella damascena L. Essential Oil-A Valuable Source of beta-Elemene for Antimicrobial Testing. Sieniawska, E., R. Sawicki, J. Golus, M. Swatko-Ossor, G. Ginalska, and K. Skalicka-Wozniak. Molecules, 2018. 23(2): p. E256. PMID[29382097].
[PubMed]. TB_03_2018.


30. Synthesis of Sulfamide Analogues of Deoxthymidine monophosphate as Potential Inhibitors of Mycobacterial Cell Wall Biosynthesis. Suthagar, K., W. Jiao, H. Munier-Lehmann, and A.J. Fairbanks. Carbohydrate Research, 2018. 457: p. 32-40. PMID[29348046].
[PubMed]. TB_03_2018.


31. Planarity of Heteroaryldithiocarbazic acid Derivatives Showing Tuberculostatic Activity: Structure-Activity Relationships. Szczesio, M., J. Golka, I. Korona-Glowniak, C. Orlewska, K. Gobis, and A. Olczak. Acta Crystallographica. Section C, Structural Chemistry, 2018. 74(Pt 3): p. 400-405. PMID[29504572].
[PubMed]. TB_03_2018.


32. Antimycobacterial Drug Discovery Using Mycobacteria-infected Amoebae Identifies Anti-infectives and New Molecular Targets. Trofimov, V., S. Kicka, S. Mucaria, N. Hanna, F. Ramon-Olayo, L.V. Del Peral, J. Lelievre, L. Ballell, L. Scapozza, G.S. Besra, J.A.G. Cox, and T. Soldati. Scientific Reports, 2018. 8(1): p. 3939. PMID[29500372]. PMCID[PMC5834492].
[PubMed]. TB_03_2018.


33. Solid-phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B Analogs. Tsutsumi, L.S., J.M. Elmore, U.T. Dang, M.J. Wallace, R. Marreddy, R.B. Lee, G.T. Tan, J.G. Hurdle, R.E. Lee, and D. Sun. ACS Combinatorial Science, 2018. 20(3): p. 172-185. PMID[29431987].
[PubMed]. TB_03_2018.


34. 1,3,5-Triazaspiro[5.5]undeca-2,4-dienes as Selective Mycobacterium tuberculosis Dihydrofolate reductase Inhibitors with Potent Whole Cell Activity. Yang, X., W. Wedajo, Y. Yamada, S.-L. Dahlroth, J.J.-L. Neo, T. Dick, and W.-K. Chui. European Journal of Medicinal Chemistry, 2018. 144: p. 262-276. PMID[29274493].
[PubMed]. TB_03_2018.


35. Identification of Novel Coumestan Derivatives as Polyketide synthase 13 Inhibitors against Mycobacterium tuberculosis. Zhang, W., S. Lung, S.-H. Wang, X.-W. Jiang, F. Yang, J. Tang, A.L. Manson, A.M. Earl, H. Gunosewoyo, W.R. Bishai, and L.-F. Yu. Journal of Medicinal Chemistry, 2018. 61(3): p. 791-803. PMID[29328655].
[PubMed]. TB_03_2018.

Patent Citations

36. Preparation of Pyridophenoxazinecarboxylates as Bacterial Topoisomerase I Inhibitors with Antibacterial Activity.Tse-Dinh, Y.-C. and D. Sun. Patent. 2018. 2017-15707537 20180079757: 34pp.
[Patent]. TB_03_2018.

Database last updated: September 2018